CIK 0001574232 · Non-accelerated filer
Addex Therapeutics Ltd.
Sign in to watch- Ticker
- ADXN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 01141228841555
- Business address
- CHEMIN DES MINES 9, GENEVA, Switzerland, CH-1202
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | Nunn Jason Raleigh Director | Returned to the company | −219,561 | 0 | ||
| 2026-09-02 | Nunn Jason Raleigh Director | Grant or award | +219,561 | 219,561 | ||
| 2026-09-02 | Nunn Jason Raleigh Director | Returned to the company · Stock-option (Right to Buy) | −50,000 | 0 | ||
| 2026-09-02 | Nunn Jason Raleigh Director | Grant or award · Stock-option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-09-02 | Mills Roger CHIEF MEDICAL OFFICER | Returned to the company | −392,837 | 393,139 | ||
| 2026-09-02 | Mills Roger CHIEF MEDICAL OFFICER | Grant or award | +392,837 | 785,976 | ||
| 2026-09-02 | Mills Roger CHIEF MEDICAL OFFICER | Returned to the company · Stock-option (Right to Buy) | −50,000 | 0 | ||
| 2026-09-02 | Mills Roger CHIEF MEDICAL OFFICER | Grant or award · Stock-option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-09-02 | Manke Isaac Director | Returned to the company | −219,561 | 0 | ||
| 2026-09-02 | Manke Isaac Director | Grant or award | +219,561 | 219,561 | ||
| 2026-09-02 | Manke Isaac Director | Returned to the company · Stock-option (Right to Buy) | −50,000 | 0 | ||
| 2026-09-02 | Manke Isaac Director | Grant or award · Stock-option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-09-02 | Lawton Vincent Michael Director | Returned to the company | −2,507,487 | 500 | ||
| 2026-09-02 | Lawton Vincent Michael Director | Grant or award | +2,507,487 | 2,507,987 | ||
| 2026-09-02 | Lawton Vincent Michael Director | Returned to the company · Stock-option (Right to Buy) | −501,598 | 0 | ||
| 2026-09-02 | Lawton Vincent Michael Director | Grant or award · Stock-option (Right to Buy) | +501,598 | 501,598 | ||
| 2026-09-02 | Hill Raymond George Director | Returned to the company | −1,365,532 | 0 | ||
| 2026-09-02 | Hill Raymond George Director | Grant or award | +1,365,532 | 1,365,532 | ||
| 2026-09-02 | Hill Raymond George Director | Returned to the company · Stock-option (Right to Buy) | −273,107 | 0 | ||
| 2026-09-02 | Hill Raymond George Director | Grant or award · Stock-option (Right to Buy) | +273,107 | 273,107 |
Page 2 of 3 · 44 trades